Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
2.280
-0.190 (-7.69%)
Jul 15, 2025, 4:00 PM - Market closed
Humacyte Market Cap
Humacyte has a market cap or net worth of $353.67 million as of July 16, 2025. Its market cap has decreased by -36.81% in one year.
Market Cap
353.67M
Enterprise Value
373.34M
1-Year Change
-36.81%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $353.67M, an increase of 184.51%. That is a compound annual growth rate of 25.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 353.67M | -45.57% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 693.50B |
| Johnson & Johnson | 373.10B |
| AbbVie | 327.77B |
| Novo Nordisk | 308.09B |
| UnitedHealth Group | 266.22B |
| Novartis AG | 237.08B |
| Abbott Laboratories | 227.80B |
| AstraZeneca | 222.35B |